Ralf Jutvik has been awarded “Entrepreneur of the year 2021” by the local Business Association in Kungsbacka. Below you can see a recording from the ceremony with english subtitles.
Why not meet us online?
Press release 2020-12-07
Biotech AB makes changes in leadership to strengthen growth
Biotech AB has appointed Dr Fritiof Pontén as new CEO and Anders Grahn as working Chairman of the Board of Directors. This strategic re-organisation will further strengthen the company’s position as an internationally well recognized distributor within the life science industry.
Dr Pontén has a PhD in organic chemistry and 17 years experience from AstraZeneca where he was working with drug development from very early to IND phase including process and technology development. Before he joined Biotech AB as R&D Manager in 2018 he was CEO of the biopharmaceutical company QureTech Bio AB in Umeå, Sweden.
Beside the responsibility as Chairman Anders Grahn will now focus his work on sales and business development. Under his leadership Biotech AB has developed to be an established and leading supplier within the life science industry. Mr Grahn has been CEO since he in 2007 co-founded the company, together with the serial entrepreneur Ralf Jutvik.
”This is perfect timing for the next step in the growth of Biotech AB that will enable us to reach new markets with established and new products”, says Ralf Jutvik.
Fritiof Pontén comments: ”Biotech AB has a dedicated team and an exciting role in providing great fluidic solutions to instrument manufactures and distributors. I see many new opportunities to bring innovative products to these customers”
Fritiof Pontén CEO
E-mail/Phone: firstname.lastname@example.org +46 722 119 101
Anders Grahn Chairman of the Board of Directors
E-mail/Phone: email@example.com +46 702 444 644
About Biotech AB
Biotech AB supplies great fluidic components to manufacturers of advanced scientific instrumentation & distributors around the world. Biotech AB is the Global Premium Distributor of IDEX Health & Science, and have offices in Europe, US and Japan. Biotech AB help our customers eliminate troubles with bubbles with our customized degassing solutions. The Biotech group had 2019 a turnover of around 7 MUSD.
Why not meet us online?
Not much can replace a meeting in reality but in these Corona-times one has to be inventive. Customer service has always been a high priority for us at Biotech and now we can offer at face-to-face meeting, where we could talk about things on YOUR mind. We can for instance discuss:
or anything YOU want to talk about. Please call +46 300 569 180 or send us an e-mail to firstname.lastname@example.org and we will get back to you to set up an online meeting.
We are looking forward to hear from you!
Anders, Fritiof and the Biotech team
Biotech har blivit uppmärksammat i lokaltidningen Norra Halland, som besökte oss och skrev en lång artikel om vår verksamhet. Vi är både glada och stolta över att vi på detta sätt blivit uppmärksammad för verksamhet. Artikeln kan i sin helhet läsas på denna länk.
Translation in English:
Biotech has been noted in the local newspaper Norra Halland, which visited us and wrote a long article about our business. We are both happy and proud that in this way we have been made aware of our business. The article can be read in full on this link.
The awarding of the “Top Performing Company 2019” to Biotech for the second year in a row has now gained attention in the local press. The municipality and the newspaper Norra Halland have noted on their websites that the company belongs to the exclusive crowd (0,7 %) of Swedish companies, which lives up to the high standards for the award. The founder of the award, which has been awarded for the last fifteen years, is Veckans Affärer, one of Sweden’s leading financial magazines and the credit information company Bisnode, specialized in producing high-quality business, credit and market information. To qualify for the award, the company must meet the requirements for growth, profit, return, efficiency, capital structure and financing for at least four years.
The company’s CEO Anders Grahn says “we are proud of the award and we have exciting projects underway and are planning for continued expansion with more employees shortly to ensure our growth.”
We are happy to announce that Biotech AB has been awarded Top Performing Company for the second year in a row.
This means that Biotech belongs to an exclusive group of companies who meet the standards below, which only 0.07 % of the Swedish companies does.
For a company to be classified as a Top Performing Company, “it must meet a number of high criteria. It is about increasing both sales and profits while at the same time the company must demonstrate stability and long-term business. The criteria must be met for at least four consecutive years in order to be included in the exclusive list.”
BIOTECH I KUNGSBACKA AB has on 23 October 2019 attained the status of UC GOLD (HIGHEST CREDITWORTHINESS)
UC GOLD accreditation testifies that BIOTECH I KUNGSBACKA AB is a stable, reliable partner with which to do business. This credit rating is based on UC Risk Corporate, the market’s most reliable model for credit assessment. Updated on a daily basis, UC Risk indicates the likelihood of a company becoming insolvent within one year.
Biotech AB has expanded the headquarter in Onsala, Sweden. The official opening ceremony was attended by Distribution sales manager André Meyer from IDEX Health and Science, who cut the ribbon to the new conference room in the building. The new facilities have increased the office space by nearly 50% and makes it easier to welcome visitors for product training and technical support. Equipped with new video conference equipment, the new space also facilitates remote meetings, bringing customers all over the world closer to Biotech’s technical expertise and to R&D Manager Dr. Fritiof Pontén, while minimizing travelling. You are most welcome to visit Biotech in Onsala or set up an online meeting to discuss your needs in degassing and components for fluidic systems.
Dr Fritiof Pontén is now onboard!
Dr. Fritiof Pontén has a solid experience of e.g. drug development gathered during 17 years at Astra Zeneca, including a wide range of drug candidates projects ranging from discovery to late stage of preclinical studies. In his role as a Senior Scientist and PhD in synthetic Organic Chemistry from Lund University he has obtained skills further through courses and training programs.
In particular he and his team´s primary tool, has been liquid chromatography – primarily analytical, but also preparative. He was also a key person in the development of the combinatorial chemistry, back in the 20th century.
He lives with his wife Margaretha half an hour from this office and ”onboard” is the proper term for Fritiof, since his hobby is sailing. His title will be Manager for Research and Development.
Having a background in organic chemistry and being a Senior Scientist a fair portion of his activity will be calling on high level analytical Biotech customers and OEM:s globally.
We welcome Fritiof in the beginning of August 2018.